Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas
- 1 December 1989
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 17 (6), 1129-1139
- https://doi.org/10.1016/0360-3016(89)90518-x
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Computerized optimization of 125I implants in brain tumorsInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Integration of magnetic resonance imaging into radiation therapy treatment planning: i. technical considerationsInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomasJournal of Neurosurgery, 1986
- Dosimetry of CT-guided volumetric IR-192 brain implantInternational Journal of Radiation Oncology*Biology*Physics, 1986
- On a method of dosimetry planning and implantation of 125I for interstitial irradiation of malignant gliomasJournal of Neuro-Oncology, 1986
- 125I Interstitial brachytherapy for primary malignant brain tumors: Technical aspects of treatment planning and implantation methodsInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Radiation Brain Damage Induced by Interstitial 125I Sources: A Canine Model Evaluated by Quantitative Computed TomographyNeurosurgery, 1985
- Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiformeJournal of Neurosurgery, 1983
- Interstitial Irradiation of Brain TumorsNeurosurgery, 1981
- Spinal subarachnoid metastasis from primary intracranial glioblastoma multiformeCancer, 1978